Investigations into the environmental conditions experienced during ambient sample transport: Impact to dried blood spot sample shipments

Bioanalysis

Volumn 3, Issue 14, 2011, Pages 1625-1633

  Bowen, Chester L ^a   Dopson, Wesley ^b   Kemp, Daniel C ^a   Lewis, Mark ^b   Lad, Rakesh ^b   Overvold, Carol ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CONTAINER; COST EFFECTIVENESS ANALYSIS; DRIED BLOOD SPOT; DRIED MATRIX SPOT; DRUG INDUSTRY; ENVIRONMENTAL FACTOR; ENVIRONMENTAL MONITORING; ENVIRONMENTAL TEMPERATURE; HUMIDITY; SHIPPING; TEMPERATURE;

DRIED BLOOD SPOT TESTING; ENVIRONMENT; HUMANS; SPECIMEN HANDLING;

EID: 79960483479     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.128     Document Type: Article

References (11)

1. Mei J, Alexander J, Adam B, Hannon W. Innovative non- or minimally-invasive technologies for monitoring health and nutritional status in mothers and young children. Am. Soc. Nutri. Sci. 131(5), 1631S-1636S (2001).
2. Therrell BL, Hannon WH, Pass KA et al. Guidelines for the retention, storage and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biocem. Mol. Med. 57, 116-124 (1996). (Pubitemid 26142732)
3. Edelbroek P, van der Heijden J, Stolk L. Dried blood spot methods in therapeutic drug monitoring: methods, assays and pitfalls. Ther. Drug Mon. 31(3) 327-336 (2009).
4. Li W, Tse L. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24, 49-65 (2010).
5. Kehler J, Bowen C, Boram S, Evans C. Application of DBS for quantitative assessment of the peptide exenden-4; comparison of plasma and DMS method by UHPLC-MS/MS. Bioanalysis 2(8), 1461-1468 (2010).
6. Barfield M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantitation of acetaminophen in toxicokinetic studies. J. Chromatogr. B 870, 32-37 (2008).
7. Christianson C, Johnson C, Sheaff C, Laine D, Zimmer J, Needham S. Dried matrix spot analysis - analysis of drugs from tears and other translucent fluids using a novel color indicating technology. Poster Presented at: CPSA. From Data to Biology: Analytical Measurements to Drive Pharmaceutical R&D. Langhorn, PA (USA), October 2010.
8. Van Amsterdam P, Waldrop C. The application of dried blood spot sampling in global clinical trials. Bioanalysis 2(11), 1783-1786 (2010).
9. Denniff P, Spooner N. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. Bioanalysis 2(11), 1817-1822 (2010).
10. Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
11. Johannessen A. Dried blood spots in HIV monitoring: application in resource-limited settings. Bioanalysis 2(11), 1893-1908 (2010